Meta-analysis of association between Helicobacter pylori infection and multiple sclerosis

Gang Yao1, Ping Wang2, Xiang-Dan Luo3

  • 1Department of Neurology, The Second Hospital of Jilin University, Changchun, Jilin, China; Applied Immunology & Immunotherapy, Department of Clinical Neuroscience, Karolinska Institutet, Center for Molecular Medicine, Karolinska Hospital at Solna, Stockholm, Sweden.

Neuroscience Letters
|April 2, 2016
PubMed

Insights

Helicobacter pylori (H. pylori) infection is less common in multiple sclerosis (MS) patients compared to healthy individuals. This suggests H. pylori may have a protective effect against MS, particularly in Western populations.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Epidemiology

Background:

  • The relationship between Helicobacter pylori (H. pylori) infection and multiple sclerosis (MS) remains debated.
  • Existing research shows conflicting results regarding H. pylori prevalence in MS patients versus controls.

Purpose of the Study:

  • To conduct a meta-analysis to estimate the prevalence of H. pylori infection in MS patients and healthy controls.
  • To clarify the association between H. pylori infection and MS risk.

Main Methods:

  • A systematic literature search was performed on PubMed and EMBASE.
  • Nine eligible studies comprising 1553 MS patients and 1253 controls were included in the meta-analysis.

Main Results:

  • The overall prevalence of H. pylori infection was lower in MS patients (24.66%) than in controls (31.84%), with a significant inverse association (OR=0.69).
  • Subgroup analysis indicated a significantly lower prevalence in Western countries (OR=0.63) but not in Eastern countries (OR=0.79).

Conclusions:

  • H. pylori infection is negatively correlated with MS, suggesting a potential protective role, especially in Western populations.
  • Further large-scale, prospective studies are warranted to confirm if H. pylori infection is a protective factor against MS.

Related Concept Videos

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
2.0K
Peptic Ulcer01:27

Peptic Ulcer

Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
20
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
759
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.5K
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.5K